81.39MMarket Cap-1167P/E (TTM)
3.8500High3.7000Low19.49KVolume3.8500Open3.8500Pre Close73.70KTurnover0.09%Turnover RatioLossP/E (Static)21.59MShares7.420052wk High1.82P/B80.79MFloat Cap1.010052wk Low--Dividend TTM21.43MShs Float309.6000Historical High--Div YieldTTM3.90%Amplitude1.0100Historical Low3.7810Avg Price1Lot Size
Aileron Therapeutics Stock Forum
NEWS
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
NEWS
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Aileron Therapeutics, Inc. announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in IPF. Low-dose LTI-03 showed reductions in profibrotic proteins, increased expression of biomarkers, and was well-tolerated. Positive trends were observed in seven out of eight biomarkers. Data from Cohort 2 is expec...
No comment yet